Features of neuropsychological characteristics of patients with arterial hypertension

Introduction. The significant pathogenetic effect of arterial hypertension on the development of cognitive and psycho-emotional disorders, on the one hand, and the lack of algorithms for identifying and managing patients with comorbid neurocognitive disorders in therapeutic practice, on the other hand, determines the relevance of studying this problem.
Aim. To study neuropsychological characteristics of patients with arterial hypertension in therapeutic practice.
Materials and methods. A total of 508 patients with arterial hypertension were enrolled in the study. All study participants underwent the clinical examination and neuropsychological tests: Montreal Cognitive Assessment Scale (MoCA test), Schulte tables, Categorical Verbal Fluency Test, Tracking Test, MFI-20 asthenia self-assessment questionnaire, Reeder's Test, Maastricht Questionnaire, and Hospital Anxiety and Depression Scale (HADS).
Results. The analysis of neuropsychological testing results of patients with hypertension showed that almost all the techniques identified deviations from the  reference ranges in  most of  the study subjects. 85% of  patients had decreased total score of cognitive functions assessed in terms of MoCA test scores, 83% of patients showed increased time in performing tracking test part A and 74% patients showed increased time in performing part B, and there was also a large difference between the  time spent on performing parts B and A  of the  test; 49% of  patients demonstrated decreased speed in  performing the  Schulte test. Th psycho-emotional state test results showed a  high level of  psycho-emotional stress in  80.5%, vital exhaustion in 78% and fatigue in 96% of patients.
Conclusions. In this study, the  neuropsychological testing results of  patients with hypertension showed decreased total scores of cognitive functions and individual parameters of the cognitive spectrum, such as attention focusing, information processing speed, memory, speech function and executive functions combined with a high level of psycho-emotional stress, fatigue and anxiety.

1. Drapkina O.M., Kontsevaya A.V., Kalinina A.M., Avdeev S.N., Agaltsov M.V., Alexandrova L.M. et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3235.

2. Drapkina O.M., Shishkova V.N., Kotova M.B. Psychoemotional risk factors of chronic non-communicable diseases in outpatient practice. Methodological recommendations for therapists. Cardiovascular Therapy and Prevention. 2022;21(10):3438. (In Russ.) https://doi.org/10.15829/1728-8800-2022-323510.15829/1728-8800-2022-3438.

3. Shishkova V.N. Cognitive disorders in patients with cerebrovascular diseases in therapeutic practice: diagnostic and management algorithms. Meditsinskiy Sovet. 2022;16(23):33–40. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-23-33-40.

4. Shishkova V.N. Cognitive impairments as a universal clinical syndrome in a therapist’s practice. Terapevticheskii Arkhiv. 2014;86(11):128–134. (In Russ.) Available at: https://www.mediasphera.ru/issues/terapevticheskijarkhiv/2014/11/030040-366020141123?ysclid=leqpc61z8l929807619.

5. Shishkova V.N. The significance of arterial hypertension in the development of brain damage – from mild cognitive impairment to dementia. Systemic Hypertension. 2014;11(1):45–51. Available at: https://www.syst-hypertension.ru/jour/article/view/336.

6. Shishkova V.N. Neuroprotection in patients with arterial hypertension: minimizing an unfavorable prognosis. Terapevticheskii Arkhiv. 2014;86(8):113–118. (In Russ.) Available at: https://www.mediasphera.ru/issues/terapevticheskij-arkhiv/2014/8/downloads/ru/030040-36602014821.

7. Suslina Z.A., Varakin Yu.Ya., Vereshchagin N.V. Vascular diseases of the brain: Epidemiology. Fundamentals of prevention. Moscow: MEDpress-inform; 2009. 352 p. (In Russ.) Available at: https://reallib.org/reader?file=720452&ysclid=leqopo0ye3970618157.

8. Parfenov V.A. Dyscirculatory encephalopathy and vascular cognitive disorders. Moscow: IMA-PRESS; 2017. 128 p. Available at: https://nnp.ima-press.net/nnp/article/viewFile/841/732.

9. Wahlung L., Erkinjuntti L., Gauthier S. (eds.). Cardiovascular disease, cognitive decline and dementia. Vascular cognitive impairment in clinical practice. Cambridge; 2009, pp. 166–177. https://doi.org/10.1017/CBO9780511575976.014.

10. Oganov R.G., Olbinskaya L.I., Smulevich A.B., Vane A.M., Arobizhev M.Yu., Shalnova C.A. et al. Depression and depressive spectrum disorders in general medical practice. The results of the COMPASS program. Kardiologiya. 2004;(1):48–54. (In Russ.) Available at: https://www.researchgate.net/publication/8569295_Depressions_and_disorders_of_depressive_spectrum_in_general_medical_practice_Results_of_the_COMPAS_program.

11. Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M. et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treat ment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4–14. (In Russ.) https://doi.org10.15829/1728-8800-2014-4-4-14.

12. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–223. https://doi.org/10.1016/S0140-6736(05)17741-1.

13. Parfenov V.A., Starchina Yu.A. Cognitive impairment in patients with hyper tension and their treatment. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(1):27–33. (In Russ.) Available at: https://doi.org/10.14412/2074-2711-2011-130.

14. Cui J., Yu R., Li M., Gao J., Cui Y. Intervention affects the cognitive performance of middle-aged patients with essential hypertension. Int J Clin Exp Med. 2016;9(1):308–315. Available at: https://e-century.us/files/ijcem/9/1/ijcem0014821.pdf.

15. Bucur B., Madden D.J. Effects of adult age and blood pressure on executive function and speed of processing. Experimental Aging Research. 2010;36(2):153–168. https://doi.org/10.1080/03610731003613482.

16. Shishkova V.N. Cognitive and emotional disorders in patients with chronic heart failure: prospects for detection and correction. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(3):87–93. (In Russ.) https://doi.org/10.14412/2074-2711-2022-3-87-93.

17. Shishkova V.N. At the reception, an elderly comorbid patient: we place accents. Consilium Medicum. 2019;21(9):48–53. (In Russ.) https://doi.org/10.26442/20751753.2019.9.190500.

18. Hо A.K., Thorpe C.T., Pandhi N., Palta M., Smith M.A., Johnson H.M. Association of Anxiety and Depression with Hypertension Control: A U.S. Multi-Disciplinary Group Practice Observational Study. J Hypertens. 2015;33(11):2215–2222. https://doi.org/10.1097/HJH.0000000000000693.

19. Player M.S., Peterson L.E. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2011;41(4):365–377. https://doi.org/10.2190/PM.41.4.f.

20. Alosco M.L., Gunstad J., Beard C., Xu X., Clark U.S., Labbe D.R. et al. The synergistic effects of anxiety and cerebral hypoperfusion on cognitive dysfunction in older adults with cardiovascular disease. J Geriatr Psychiatry Neurol. 2015;28(1):57–66. https://doi.org/10.1177/0891988714541871.

21. Gualtieri C.T., Morgan D. The frequency of cognitive impairment in patients with anxiety, depression and bipolar disorder: an uncounted source of variance in clinical trials. J Clin Psychiatry. 2008;69(7):1122–1130. https://doi.org/10.4088/jcp.v69n0712.

22. Starchina Yu.A., Parfenov V.A., Chazova I.E., Sinitsyn V.E., Pustovitova T.S., Kolos I.P., Ustyuzhanin D.V. Cognitive function and the emotional state of stroke patients on antihypertensive therapy. Neurosci Behav Physiol. 2007;37(1):13–17. https://doi.org/10.1007/s11055-007-0143-z.

23. Tkacheva O.N., Yakhno N.N., Neznanov N.G., Levin O.S., Gusev E.I., Martynov M.Yu. et al. Cognitive disorders in the elderly and senile. Clinical recommendations. Moscow; 2020. (In Russ.) Available at: https://cr.minzdrav.gov.ru/schema/617_1.

24. Levin O.S. Diagnosis and treatment of cognitive impairment and dementia in clinical practice. Moscow: MEDpress-inform; 2019. 448 p. (In Russ.) Available at: https://static-sl.insales.ru/files/1/873/11576169/original/dia_i_lech_kogn_nar_i_dem_v_klinich_pr.pdf.

25. Dichgans M., Leys D. Vascular Cognitive Impairment. Circ Res. 2017;120(3):573–591. https://doi.org/10.1161/CIRCRESAHA.116.308426.

26. Ghafar M.Z.A.A., Miptah H.N., O’Caoimh R. Cognitive screening instruments to identify vascular cognitive impairment: A systematic review. Int J Geriatr Psychiatry. 2019;34(8):1114–1127. https://doi.org/10.1002/gps.5136.

27. Chen T.B., Yiao S.Y., Sun Y., Lee H.J., Yang S.C., Chiu M.J. et al. Comorbidity and dementia: A nationwide survey in Taiwan. PLоS ONE. 2017;12(4):e0175475. https://doi.org/10.1371/journal.pone.0175475.